}

Mark Epply

MARK EPPLY, CPA, MBA:  A Consultant with NMG, Mr. Epply has a strong background in the operational and financial aspects of the clinical and anatomic laboratory industry.  He was the Chief Financial Officer of PathLab, Inc. from 1989 to 2003, where he was responsible for the company’s financial management, budgeting and financial reporting and analysis.  During Mr. Epply’s tenure with PathLab the company experienced a revenue increase from $9 million to $74 million through internal growth and acquisitions.  Mr. Epply performed the due diligence on numerous laboratory acquisitions and provided the complete data package for the sale of PathLab in 1994 when the company was sold to a private group, and again in 2001 when the company was sold to LabCorp.  Mr. Epply designed PathLab’s budgeting template and implemented many financial, operational and productivity reporting systems that contributed to PathLab becoming one of the most efficient and profitable laboratory companies in the country.  Previously, Mr. Epply was a senior accountant with the international accounting firm of PricewaterhouseCoopers, and a manager with the New England regional accounting firm of Berry, Dunn, McNeil & Parker.

Mr. Epply received his MBA from the University of New Hampshire and is a licensed CPA in New Hampshire and Massachusetts.  He is a member of the American Institute of Certified Public Accountants (AICPA), the New Hampshire Society of Certified Public Accountants (NHSCPA), and the Healthcare Financial Management Association (HFMA).

 

To reach Mark Epply, please fill out our contact form.

Comments are closed.

Share This
twitter.com
LinkedIn.com
website by filias + APART